Prince Bonsu, MD | |
12500 Willowbrook Rd, Cumberland, MD 21502-6393 | |
(240) 964-3306 | |
Not Available |
Full Name | Prince Bonsu |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 8 Years |
Location | 12500 Willowbrook Rd, Cumberland, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053774331 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | D0092559 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Western Maryland Regional Medical Center | Cumberland, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North American Partners In Anesthesia Maryland Llc | 1850283144 | 77 |
News Archive
Forest Laboratories, Inc. announced today that its Canadian subsidiary, Forest Laboratories Canada Inc. has received a Notice of Compliance from Health Canada for BYSTOLIC (nebivolol) tablets, a once daily beta blocker for the treatment of hypertension.
Breast cancer is the most common cancer with the highest mortality rate. Swift detection and diagnosis diminish the impact of the disease.
The antidepressant fluoxetine causes bone loss by instructing the brain to send out signals that increase bone breakdown, but a beta-blocker can intercept the signals, a new study in mice has found.
Cellumen, Inc., a discovery and early safety assessment company, today announced that its in vitro Rat Hepatocyte Early Safety Assessment Panel provides increased predictivity for human drug induced liver injury (DILI) equivalent to that of a recently published panel comprised of human hepatocytes. The implications of this study have a significant impact on cost and throughput for in vitro human DILI predictive solutions.
› Verified 1 days ago
Entity Name | North American Partners In Anesthesia Maryland Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093707879 PECOS PAC ID: 1850283144 Enrollment ID: O20040330000405 |
News Archive
Forest Laboratories, Inc. announced today that its Canadian subsidiary, Forest Laboratories Canada Inc. has received a Notice of Compliance from Health Canada for BYSTOLIC (nebivolol) tablets, a once daily beta blocker for the treatment of hypertension.
Breast cancer is the most common cancer with the highest mortality rate. Swift detection and diagnosis diminish the impact of the disease.
The antidepressant fluoxetine causes bone loss by instructing the brain to send out signals that increase bone breakdown, but a beta-blocker can intercept the signals, a new study in mice has found.
Cellumen, Inc., a discovery and early safety assessment company, today announced that its in vitro Rat Hepatocyte Early Safety Assessment Panel provides increased predictivity for human drug induced liver injury (DILI) equivalent to that of a recently published panel comprised of human hepatocytes. The implications of this study have a significant impact on cost and throughput for in vitro human DILI predictive solutions.
› Verified 1 days ago
Entity Name | Cumberland Anesthesia Ams Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033531785 PECOS PAC ID: 4981825056 Enrollment ID: O20141015001480 |
News Archive
Forest Laboratories, Inc. announced today that its Canadian subsidiary, Forest Laboratories Canada Inc. has received a Notice of Compliance from Health Canada for BYSTOLIC (nebivolol) tablets, a once daily beta blocker for the treatment of hypertension.
Breast cancer is the most common cancer with the highest mortality rate. Swift detection and diagnosis diminish the impact of the disease.
The antidepressant fluoxetine causes bone loss by instructing the brain to send out signals that increase bone breakdown, but a beta-blocker can intercept the signals, a new study in mice has found.
Cellumen, Inc., a discovery and early safety assessment company, today announced that its in vitro Rat Hepatocyte Early Safety Assessment Panel provides increased predictivity for human drug induced liver injury (DILI) equivalent to that of a recently published panel comprised of human hepatocytes. The implications of this study have a significant impact on cost and throughput for in vitro human DILI predictive solutions.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Prince Bonsu, MD 439 Cumberland St, Cumberland, MD 21502-2050 Ph: () - | Prince Bonsu, MD 12500 Willowbrook Rd, Cumberland, MD 21502-6393 Ph: (240) 964-3306 |
News Archive
Forest Laboratories, Inc. announced today that its Canadian subsidiary, Forest Laboratories Canada Inc. has received a Notice of Compliance from Health Canada for BYSTOLIC (nebivolol) tablets, a once daily beta blocker for the treatment of hypertension.
Breast cancer is the most common cancer with the highest mortality rate. Swift detection and diagnosis diminish the impact of the disease.
The antidepressant fluoxetine causes bone loss by instructing the brain to send out signals that increase bone breakdown, but a beta-blocker can intercept the signals, a new study in mice has found.
Cellumen, Inc., a discovery and early safety assessment company, today announced that its in vitro Rat Hepatocyte Early Safety Assessment Panel provides increased predictivity for human drug induced liver injury (DILI) equivalent to that of a recently published panel comprised of human hepatocytes. The implications of this study have a significant impact on cost and throughput for in vitro human DILI predictive solutions.
› Verified 1 days ago
Dr. Alvin William Davis, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 600 Memorial Ave, Cumberland, MD 21502 Phone: 301-723-4965 | |
Dr. Gerald Goldstein, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 Memorial Ave, Suite 307, Cumberland, MD 21502 Phone: 301-723-4965 | |
Dr. Rohan Saint Aubyn Mullings, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 904 Seton Dr, Suite 202, Cumberland, MD 21502 Phone: 301-723-4965 | |
Dr. David Anthony Marshall, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 240-964-7000 | |
Ramin Ghesmati Kalourazi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 Memorial Ave, Cumberland, MD 21502 Phone: 301-723-5122 | |
Wyllys Royce Hodges Iii, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 Memorial Ave, Cumberland, MD 21502 Phone: 301-723-4965 |